Jill Buckley Joins Foresight Group International as VP of Business Transition Services

Share Article

New Administrator to Oversee a Growing Component of Foresight's Services

Based in Durham, North Carolina, Jill Buckley has joined Foresight Group International AG as the Vice President of Business Transition Services.

With over 25 years of experience within the life sciences industry, including over 13 years within Pharmacovigilance, Jill brings superior expertise to a rapidly growing component of Foresight’s service offerings.

“Given Jill’s history, she is the ideal candidate to oversee the growth and optimization of our business transition services,” said Brian Dinardo, Global Head of Operations for Foresight. “We are looking forward to leveraging her insightful and thorough approach.”

Jill was previously the Vice President of Global Pharmacovigilance Operations at United Therapeutics Corporation. She was also Vice President and Global Head, Integrated Service Operations, Lifecycle Safety at Quintiles, Inc. Prior to acquisition by Pfizer, Jill served as Senior Vice President of Drug Safety and Pharmacovigilance at King Pharmaceuticals, Inc. where she built the department responsible for safety monitoring of all marketed and investigational products. She also oversaw pharmacovigilance, clinical safety, risk management, safety evaluation, and signal detection. She chaired King’s Product Safety Committee and later was the Vice-Chair of the Medicines Safety Board.

Prior to joining King, Jill worked in clinical research and regulatory affairs at Gilead Sciences, Inc., Quintiles and Burroughs Wellcome Co., developing expertise in protocol development, clinical trial monitoring, regulatory application preparation, and FDA interactions.

Jill earned her Doctor of Pharmacy degree from the University of Michigan. She also completed a residency in hospital pharmacy at Duke University Medical Center and obtained a fellowship in drug development and clinical research at the University of North Carolina.

Foresight Group International AG is a global professional services company focused exclusively on clinical and post-marketing drug safety and surveillance and risk management services and solutions. Our seasoned drug safety and pharmacovigilance experts are recognized in every major PV market in the world: North America, Europe, India, and Asia. Our best-in-class partnership with Oracle for Oracle Argus Safety Suite, coupled with our deep expertise in drug safety and PV, life sciences, technology, compliance and business processes, lets Foresight offer clients the most comprehensive collection of pharmacovigilance services and solutions available in industry today. From simple software selection to business process redesign, all of our services and solutions are delivered with precise, timely, and cost-effective execution to help our clients lower operational costs, minimize potential litigation costs, and manage risk.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

John Heid
jheid@foresightgroup.com
847-970-2733
Email >
Visit website